Risk-Based Monitoring (RBM) & Remote Oversight

Tools and Dashboards for Tracking Issue Lifecycle and Aging

November 18, 2025November 15, 2025 digi

Tools and Dashboards for Tracking Issue Lifecycle and Aging Tools and Dashboards for Tracking Issue Lifecycle and Aging Managing clinical trials, especially in a regulatory landscape governed by ICH-GCP, FDA, EMA, and MHRA guidelines, necessitates robust tools and dashboards designed for effective issue lifecycle tracking and aging management. This article serves as a comprehensive step-by-step…

Issue Management & Escalation Paths

Training Study Teams on When and How to Escalate Issues

November 18, 2025November 15, 2025 digi

Training Study Teams on When and How to Escalate Issues Effective issue management and escalation are vital components of clinical trial operations. As trials become increasingly complex, study teams must be equipped with the knowledge and tools necessary for navigating potential problems. This comprehensive guide provides clinical operations, regulatory affairs, and medical affairs professionals with…

Issue Management & Escalation Paths

Common Pitfalls in Issue Management and How to Design Around Them

November 18, 2025November 15, 2025 digi

Common Pitfalls in Issue Management and How to Design Around Them Common Pitfalls in Issue Management and How to Design Around Them In the context of managing clinical trials, particularly in sensitive areas such as prostate cancer clinical trials consortium, effective issue management is paramount. The ability to identify, address, and mitigate issues promptly ensures…

Issue Management & Escalation Paths

Designing Global vs Local Issue Management Models in Multi-Region Trials

November 18, 2025November 15, 2025 digi

Designing Global vs Local Issue Management Models in Multi-Region Trials In the complex landscape of clinical trials, especially those that span multiple regions, the design of effective issue management models is crucial for success. This article provides a comprehensive guide tailored for clinical operations, regulatory affairs, and medical affairs professionals involved in patient engagement clinical…

Issue Management & Escalation Paths

Integration of Issue Management With RBM and Central Monitoring Outputs

November 18, 2025November 15, 2025 digi

Integration of Issue Management With RBM and Central Monitoring Outputs The integration of issue management with risk-based monitoring (RBM) and central monitoring outputs represents a significant advancement in clinical research services. This tutorial provides a step-by-step guide for clinical operations, regulatory affairs, and medical affairs professionals to effectively implement these strategies. By ensuring thorough oversight…

Issue Management & Escalation Paths

Risk-Based Oversight of Home Health, Local Labs and Community Providers

November 18, 2025November 15, 2025 digi

Risk-Based Oversight of Home Health, Local Labs and Community Providers Risk-Based Oversight of Home Health, Local Labs and Community Providers In the ever-evolving landscape of clinical trials, particularly with the rise of decentralized clinical trials (DCT) and hybrid models, the need for effective risk-based monitoring (RBM) has never been more critical. This article provides a…

Oversight of DCT/Hybrid Sites

Oversight Models for Decentralized and Hybrid Clinical Trial Sites

November 18, 2025November 15, 2025 digi

Oversight Models for Decentralized and Hybrid Clinical Trial Sites Oversight Models for Decentralized and Hybrid Clinical Trial Sites The evolution of clinical trials has risen significantly due to technological advancements and changing patient expectations, leading to the emergence of decentralized and hybrid clinical trial models. These models offer potential benefits such as improved patient access…

Oversight of DCT/Hybrid Sites

Ensuring GCP Compliance Across Traditional and Virtual Site Footprints

November 18, 2025November 15, 2025 digi

Ensuring GCP Compliance Across Traditional and Virtual Site Footprints Ensuring GCP Compliance Across Traditional and Virtual Site Footprints In the evolving landscape of clinical research, ensuring compliance with Good Clinical Practice (GCP) remains a primary concern for clinical operations, regulatory affairs, and medical affairs professionals. This comprehensive guide outlines the steps necessary to ensure GCP…

Oversight of DCT/Hybrid Sites

Monitoring and Quality Management in DCT and Hybrid Trial Designs

November 18, 2025 digi

Monitoring and Quality Management in DCT and Hybrid Trial Designs In the evolving landscape of clinical research, decentralized clinical trials (DCT) and hybrid trial designs have emerged as essential methodologies, especially in the context of prostate cancer clinical trials. The complexity of these frameworks necessitates robust monitoring and quality management strategies to ensure data integrity…

Oversight of DCT/Hybrid Sites

Central Monitoring Approaches Tailored to DCT/Hybrid Ecosystems

November 18, 2025November 15, 2025 digi

Central Monitoring Approaches Tailored to DCT/Hybrid Ecosystems Central Monitoring Approaches Tailored to DCT/Hybrid Ecosystems As clinical trials increasingly adopt decentralized clinical trial (DCT) methodologies and hybrid approaches, the need for robust central monitoring techniques becomes paramount. This article serves as a comprehensive guide for clinical operations, regulatory affairs, and medical affairs professionals, detailing effective central…

Oversight of DCT/Hybrid Sites